Abstract

Missing data in clinical trials could potentially arise from the mechanism of Missing Not At Random (MNAR) . In order to understand the impact on a longitudinal clinical trial findings from missing data under the MNAR assumption, the sensitivity analyses could be carried out by multiple imputations. By progressively decreasing the treatment differences in those treated subjects who fell into an assumed MNAR pattern, the departure from Missing At Random (MAR) assumption could be investigated. This chapter aims to apply Markov Chain Monte-Carlo (MCMC) Multiple Imputation method to investigate that, under an MNAR assumption, that the missing data pattern of subjects who receive clinical trial treatment are similar to, worse than, or better than those of subjects who receive placebo with similar observed outcomes for two scenarios of early discontinuation: (1) discontinuation due to lack of efficacy and non-disease progression related Adverse Events (AEs); (2) discontinuation due to any reason. We also demonstrate how to apply MCMC multiple imputation method without assuming the data to have normal distribution.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.